Arzerra

Pharma

Novartis to challenge Roche, Sanofi with delayed MS med Kesimpta

In June, the FDA delayed its decision deadline for Novartis MS prospect ofatumumab by three months. But it turns out the agency didn't need that long.

Carly Helfand Aug 20, 2020 5:29pm

FDA hits Novartis with unexpected delay on MS drug

Jun 3, 2020 11:55am

Novartis' leukemia drug tops Sanofi's Aubagio in MS study

May 27, 2020 10:10am

Which new MS drug do doctors like best? You might be surprised

Nov 19, 2019 11:16am

Novartis' reinvented leukemia drug bests Sanofi's Aubagio in MS

Sep 13, 2019 11:18am

Novartis' Arzerra outpaces Sanofi's Aubagio in MS trial

Aug 30, 2019 9:55am